With high transmissibility and no effective vaccine or therapy, COVID-19 is now a global
pandemic. Government-coordinated efforts across the globe have focused on containment and …

Digital health technology (DHT) has the potential to revolutionize healthcare delivery but its
uptake has been low in clinical and research settings. The factors that contribute to the …

Aims To evaluate temporal trends in the enrolment of females in randomized controlled
trials (RCTs) of heart failure with reduced ejection fraction (HFrEF) published in high‐impact …

Background Clinical trials change practice in cardiology, and leading them requires research
training, mentorship, sponsorship, and networking. Women report challenges in obtaining …

Objective To describe clinical features, diagnostic findings, treatments, and outcomes in
patients with new-onset postural orthostatic tachycardia syndrome (POTS) and other autonomic …

Background: Trial steering committees (TSCs) steer the conduct of randomized controlled
trials (RCTs). We examined the gender composition of TSCs in impactful heart failure RCTs …

Background: Patient-reported outcomes (PROs) are important measures of treatment effect
and can be used to inform the approval of cardiovascular drugs and devices by the US Food …

Background Females are historically underenrolled in heart failure (HF) randomized
controlled trials (RCTs) relative to disease prevalence. Sex differences in trial flow, including …

With the advances in technology and data science, machine learning (ML) is being rapidly
adopted by the health care sector. However, there is a lack of literature addressing the health …

Women are thought to be under-represented as clinical trial participants and as clinical
trialists in heart failure. We reviewed randomized controlled trials of heart failure published in …